Daiichi Sankyo Company, Limited (4568.T)
Develops cancer drugs and heart and blood pressure medicines sold worldwide.
2,886.50-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-21.5%
The outlook
Daiichi Sankyo trades near the lower end of its 52-week range, with analyst consensus strongly bullish and an average price target about 46% above current levels. The stock shows mixed momentum relative to its moving averages, though the overall StockGlow lean is moderately bullish.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 17 analysts
Price trendMixed vs its moving averages
52-week range28% of the way from its 52-week low to high
Price targetAvg target +46% vs current price
Analyst price target
~12-month · 17 analysts4,205.29average target+45.7% vs now
Now 2,886.50
Low 2,750.00High 5,500.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.25T
52-wk high
4,178.00
52-wk low
2,390.00
50-day avg
2,638.94
200-day avg
3,049.07
Trailing P/E
20.6